Park Avenue Securities LLC Takes Position in American Healthcare REIT, Inc. $AHR

Key Points

• Park Avenue Securities LLC has acquired a new stake in American Healthcare REIT, purchasing 8,642 shares valued at approximately $318,000 in the 2nd quarter of the year.
• American Healthcare REIT recently reported earnings of $0.42 EPS, surpassing analysts' expectations, and has set its FY 2025 guidance between 1.640-1.680 EPS.
• The company announced a quarterly dividend of $0.25 to be paid on October 17th, with an annualized yield of 2.4%.

Park Avenue Securities LLC bought a new stake in American Healthcare REIT, Inc. (NYSE:AHR - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 8,642 shares of the company's stock, valued at approximately $318,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Wolff Wiese Magana LLC acquired a new stake in shares of American Healthcare REIT in the 1st quarter valued at $25,000. Physician Wealth Advisors Inc. acquired a new stake in shares of American Healthcare REIT in the 2nd quarter valued at $34,000. MassMutual Private Wealth & Trust FSB boosted its position in shares of American Healthcare REIT by 189.0% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 968 shares of the company's stock worth $29,000 after purchasing an additional 633 shares during the last quarter. Spirit of America Management Corp NY bought a new position in shares of American Healthcare REIT in the 1st quarter worth $30,000. Finally, Avalon Trust Co bought a new position in shares of American Healthcare REIT in the 1st quarter worth $36,000. 16.68% of the stock is owned by institutional investors and hedge funds.

American Healthcare REIT Stock Performance

AHR opened at $42.04 on Wednesday. The business's 50-day moving average price is $41.22 and its two-hundred day moving average price is $36.11. American Healthcare REIT, Inc. has a 1 year low of $23.66 and a 1 year high of $43.52. The company has a market capitalization of $7.09 billion, a price-to-earnings ratio of -191.09, a P/E/G ratio of 2.15 and a beta of 1.09. The company has a debt-to-equity ratio of 0.41, a current ratio of 0.48 and a quick ratio of 0.48.

American Healthcare REIT (NYSE:AHR - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.40 by $0.02. The business had revenue of $542.50 million for the quarter, compared to the consensus estimate of $539.49 million. American Healthcare REIT had a negative return on equity of 1.43% and a negative net margin of 1.56%.American Healthcare REIT's quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.33 earnings per share. American Healthcare REIT has set its FY 2025 guidance at 1.640-1.680 EPS. Equities analysts expect that American Healthcare REIT, Inc. will post 1.41 EPS for the current fiscal year.

American Healthcare REIT Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 17th. Investors of record on Tuesday, September 30th will be given a $0.25 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.4%. American Healthcare REIT's payout ratio is currently -454.55%.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Morgan Stanley restated an "overweight" rating on shares of American Healthcare REIT in a research report on Wednesday, September 3rd. KeyCorp raised their price target on American Healthcare REIT from $34.00 to $40.00 and gave the stock an "overweight" rating in a research report on Wednesday, June 11th. Royal Bank Of Canada raised their price target on American Healthcare REIT from $39.00 to $45.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 13th. Truist Financial raised their price target on American Healthcare REIT from $44.00 to $46.00 and gave the stock a "buy" rating in a research report on Tuesday, August 26th. Finally, Robert W. Baird started coverage on American Healthcare REIT in a report on Friday, July 18th. They set an "outperform" rating and a $41.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating and ten have given a Buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $44.11.

Insider Activity

In related news, EVP Mark E. Foster sold 3,850 shares of American Healthcare REIT stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $41.89, for a total value of $161,276.50. Following the sale, the executive vice president owned 59,100 shares of the company's stock, valued at approximately $2,475,699. The trade was a 6.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.00% of the company's stock.

American Healthcare REIT Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.